Baili moves its CD33 conjugate into advanced trials
The company is set to start a phase 2/3 trial this month.
Vor looks to answer the Car-T question
Can the company add a Car-T string to its stem cell transplant bow?
ASH 2024 – J&J reveals more about Lava's secret sauce
JNJ-89853413 is disclosed as the lead in the two companies' 2020 alliance.
The pieces of Vor’s puzzle start to come together
The depressed company could use Mylotarg as a stepping stone in AML.
